|
1
|
Pezzolla A, Lattarulo S, Milella M, Barile
G, Pascazio B, Ciampolillo A, Fabiano G and Palasciano N:
Incidental carcinoma in thyroid pathology: Our experience and
review of the literature. Ann Ital Chir. 81:165–169.
2010.PubMed/NCBI
|
|
2
|
Hurtado-López LM, Basurto-Kuba E, Montes
de Oca-Durán ER, Pulido-Cejudo A, Vázquez-Ortega R and
Athié-Gutiérrez C: Prevalence of thyroid nodules in the valley of
Mexico. Cir Cir. 79:114–117. 2011.PubMed/NCBI
|
|
3
|
Ramirez-Gonzalez LR, Sevilla-Vizcaino R,
Monge-Reyes P, Aldaz-Dorantes JE, Márquez-Valdez AR,
García-Martínez D, González-Ojeda A and Fuentes-Orozco C: Findings
of thyroid nodules in autopsies in western Mexico. Rev Med Inst Mex
Seguro Soc. 55:594–598. 2017.PubMed/NCBI(In Spanish).
|
|
4
|
Yu GP, Li JCL, Branovan D, McCormick S and
Schantz SP: Thyroid cancer incidence and survival in the national
cancer institute surveillance, epidemiology, and end results
race/ethnicity groups. Thyroid. 20:465–473. 2010.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Park SY, Jung YS, Ryu CH, Lee CY, Lee YJ,
Lee EK, Kim SK, Kim TS, Kim TH, Jang J, et al: Identification of
occult tumors by whole-specimen mapping in solitary papillary
thyroid carcinoma. Endocr Relat Cancer. 22:679–686. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Pinchera A: Thyroid incidentalomas. Horm
Res. 68 (Suppl 5):S199–S201. 2007.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Vigneri R, Malandrino P and Vigneri P: The
changing epidemiology of thyroid cancer: Why is incidence
increasing? Curr Opin Oncol. 27:1–7. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Vaideeswar P, Singaravel S and Gupte P:
The thyroid in ischemic heart disease: An autopsy study. Indian
Heart J. 70 (Suppl 3):S489–S491. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Davies L, Morris LGT, Haymart M, Chen AY,
Goldenberg D, Morris J, Ogilvie JB, Terris DJ, Netterville J, Wong
RJ and Randolph G: AACE Endocrine Surgery Scientific Committee.
American association of clinical endocrinologists and American
college of endocrinology disease state clinical review: The
increasing incidence of thyroid cancer. Endocr Pract. 21:686–696.
2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
American Thyroid Association (ATA)
Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid
Cancer. Cooper DS, Doherty GM, Haugen BR, Hauger BR, Kloos RT, et
al: Revised American Thyroid Association management guidelines for
patients with thyroid nodules and differentiated thyroid cancer.
Thyroid Off J Am Thyroid Association. 19:1167–1214. 2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lee YS, Lim H, Chang HS and Park CS:
Papillary thyroid microcarcinomas are different from latent
papillary thyroid carcinomas at autopsy. J Korean Med Sci.
29:676–679. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Janovsky CCPS, Bittencourt MS, de Novais
MAP, Maciel RMB, Biscolla RPM and Zucchi P: Thyroid cancer burden
and economic impact on the Brazilian public health system. Arch
Endocrinol Metab. 62:537–544. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kaliszewski K, Zubkiewicz-Kucharska A,
Kiełb P, Maksymowicz J, Krawczyk A and Krawiec O: Comparison of the
prevalence of incidental and non-incidental papillary thyroid
microcarcinoma during 2008-2016: A single-center experience. World
J Surg Oncol. 16(202)2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Slijepcevic N, Zivaljevic V, Marinkovic J,
Sipetic S, Diklic A and Paunovic I: Retrospective evaluation of the
incidental finding of 403 papillary thyroid microcarcinomas in 2466
patients undergoing thyroid surgery for presumed benign thyroid
disease. BMC Cancer. 15(330)2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Miyauchi A, Ito Y and Oda H: Insights into
the management of papillary microcarcinoma of the thyroid. Thyroid.
28:23–31. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Volante M, Collini P, Nikiforov YE,
Sakamoto A, Kakudo K, Katoh R, Lloyd RV, LiVolsi VA, Papotti M,
Sobrinho-Simoes M, et al: Poorly differentiated thyroid carcinoma:
The turin proposal for the use of uniform diagnostic criteria and
an algorithmic diagnostic approach. Am J Surg Pathol. 31:1256–1264.
2007.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Shah JP: Thyroid carcinoma: Epidemiology,
histology, and diagnosis. Clin Adv Hematol Oncol. 13 (Suppl
4):S3–S6. 2015.PubMed/NCBI
|
|
18
|
Olson E, Wintheiser G, Wolfe KM, Droessler
J and Silberstein PT: Epidemiology of thyroid cancer: A review of
the national cancer database, 2000-2013. Cureus.
11(e4127)2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Lee I, Kim HK, Soh EY and Lee J: The
association between chronic lymphocytic thyroiditis and the
progress of papillary thyroid cancer. World J Surg. 44:1506–1513.
2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Shvero J, Koren R, Shpitzer T, Feinmesser
R and Segal K: Immunohistochemical profile and treatment of
uncommon types of thyroid carcinomas. Oncol Rep. 10:2075–2078.
2003.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Cvejic D, Savin S, Petrovic I, Selemetjev
S, Paunovic I, Tatic S and Havelka M: Galectin-3 and proliferating
cell nuclear antigen (PCNA) expression in papillary thyroid
carcinoma. Exp Oncol. 27:210–214. 2005.PubMed/NCBI
|
|
22
|
Brigante G, Monzani ML, Locaso M, Gnarini
VL, Graziadei L, Kaleci S, De Santis MC, Tagliavini S, Simoni M,
Rochira V and Madeo B: De novo lesions frequently develop in adult
normal thyroid over almost six years. Front Endocrinol (Lausanne).
11(18)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Dean DS and Gharib H: Epidemiology of
thyroid nodules. Best Pract Res Clin Endocrinol Metab. 22:901–911.
2008.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ito Y, Miyauchi A and Oda H: Low-risk
papillary microcarcinoma of the thyroid: A review of active
surveillance trials. Eur J Surg Oncol. 44:307–315. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Gaman MA, Dobrica EC, Pascu EG, Cozma MA,
Epingeac ME, Gaman AM, Pantea Stoian A, Bratu OG and Diaconu CC:
Cardio metabolic risk factors for atrial fibrillation in type 2
diabetes mellitus: Focus on hypertension, metabolic syndrome and
obesity. J Mind Med Sci. 6:157–161. 2019.
|
|
26
|
Epingeac ME, Gaman MA, Diaconu C, Gad M
and Gaman AM: The evaluation of oxidative stress levels in obesity.
Rev Chim (Bucharest). 70:2241–2244. 2019.
|
|
27
|
Zimmermann MB and Galetti V: Iodine intake
as a risk factor for thyroid cancer: A comprehensive review of
animal and human studies. Thyroid Res. 8(8)2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Haymart MR, Cayo M and Chen H: Papillary
thyroid microcarcinomas: Big decisions for a small tumor. Ann Surg
Oncol. 16:3132–3139. 2009.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Girardi FM, Barra MB and Zettler CG:
Analysis of pattern of occurrence of thyroid carcinoma between 2001
and 2010. Braz J Otorhinolaryngol. 81:541–548. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Pai SA: The Washington manual of surgical
pathology. J Clin Pathol. 62:766–767. 2009.
|
|
31
|
Dumitru N, Cocolos A, Caragheorgheopol A,
Dumitrache C, Bratu OG, Neagu TP, Diaconu CC and Ghemigian A:
Collagen-the ultrastructural element of the bone matrix. Rev Chim
(Bucharest). 69:1706–1709. 2018.
|
|
32
|
Oda H, Miyauchi A, Ito Y, Yoshioka K,
Nakayama A, Sasai H, Masuoka H, Yabuta T, Fukushima M, Higashiyama
T, et al: Incidences of unfavorable events in the management of
low-risk papillary microcarcinoma of the thyroid by active
surveillance versus immediate surgery. Thyroid. 26:150–155.
2016.PubMed/NCBI View Article : Google Scholar
|
